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Abstract
Signal -transduction networks coordinate transcriptional programs activated by diverse 
extracellular stimuli, such as growth factors and cytokines. Cells receive multiple stimuli 
simultaneously, and mapping how activation of the integrated signaling network affects gene 
expression is a challenge. We stimulated colon adenocarcinoma cells with various combinations of 
the cytokine tumor necrosis factor (TNF) and the growth factors insulin and epidermal growth 
factor (EGF) to investigate signal integration and transcriptional crosstalk. We quantitatively 
linked the proteomic and transcriptomic data sets by implementing a structured computational 
approach called tensor partial least squares regression. This statistical model accurately predicted 
transcriptional signatures from signaling arising from single and combined stimuli and also 
predicted time-dependent contributions of signaling events. Specifically, the model predicted that 
an early-phase, Akt-associated signal downstream of insulin repressed a set of transcripts induced 
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by TNF. Through bioinformatics and cell-based experiments, we identified the Akt-repressed 
signal as glycogen synthase kinase 3 (GSK3)–catalyzed phosphorylation of Ser37 on the long form 
of the transcription factor GATA6. Phosphorylation of GATA6 on Ser37 promoted its degradation, 
thereby preventing GATA6 from repressing transcripts that are induced by TNF and attenuated by 
insulin. Our analysis showed that predictive tensor modeling of proteomic and transcriptomic data 
sets can uncover pathway crosstalk that produces specific patterns of gene expression in cells 
receiving multiple stimuli.
 INTRODUCTION
A goal of systems biology is to identify regulatory properties of biological networks by 
integrating experiments and kinetic models around a defined biological “parts list” (1). For 
signal transduction, such approaches have clarified the molecular pathways and regulatory 
events that can explain signaling thresholds (2–4), adaptation (5–8), and oscillations (9–15), 
as well as signal-induced cell -fate transitions (16–18). A complementary use of systems 
methods is for large-scale profiling and analysis of cellular signals in pursuit of integrative 
understanding or new molecular mechanisms (19–22). These applications favor data-driven 
models based on statistics or bioinformatics, which propose new links within the network 
that can be tested experimentally (23–28). Testing of a data-driven hypothesis about 
mechanism requires reductionist experimental approaches, even when the hypothesis itself 
emerges from network-level data (29, 30). Consequently, systems-level studies can yield 
findings that are immediately relevant to signal transduction biology (31).
Receptor-mediated signaling pathways are densely connected and exhibit nonadditive 
behaviors when two ligands activating different receptors are applied simultaneously (32–
34). Downstream of receptor activation and signal transduction, complexity increases even 
further when considering the consequences of signaling on gene regulation (35–37). 
Fortunately, new signaling synergy or antagonism does not typically emerge with more than 
two inputs (38–41), suggesting that stimulus pairs are sufficient to assess potential crosstalk. 
For systems-level discovery, this type of in-depth cellular profiling must be complemented 
by data-driven modeling and extensive mechanistic follow-up.
Here, we examined crosstalk between a proinflammatory stimulus, tumor necrosis factor 
(TNF), and one of two growth factors, insulin or epidermal growth factor (EGF), with a 
focus on signaling -network activation and downstream regulation of the transcriptome. To 
examine the interface between signal -transduction and transcription networks at the systems 
level, we built upon a preexisting compendium of signaling events collected in the 
adenocarcinoma cell line HT-29, which were initially exposed to interferon- γ (IFNγ) and 
then stimulated with TNF, EGF, and insulin in various combinations (42, 43). Because TNF, 
EGF, and insulin trigger widespread and time-dependent changes in transcript abundance 
(44–47), we collected dynamic mRNA profiles after stimulation with single or paired stimuli 
and integrated these data with the previously measured intracellular signaling events (42, 
43).
Because each signal and transcript was measured at every time point and stimulus condition, 
we could organize the signaling and transcriptomic data cubes as three-way tensors to build 
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a model constrained by the structure of the data. Model analysis together with 
bioinformatics predicted a link between Akt–glycogen synthase kinase 3 (GSK3) signaling 
and the endodermal transcription factor GATA6. We found that GSK3 phosphorylation of 
Ser37 on the long form of GATA6 (GATA6L) accelerated its degradation in cells. The 
increased turnover reduced transcriptional repression by GATA6L of genes induced by TNF. 
Collectively, our results showed that GATA6L integrated growth factor–induced signaling 
activity and inflammatory transcriptional regulation.
 RESULTS
 Cytokine combinations elicit complex changes in signaling and transcript abundance
For the signaling pathway measurements, we used data from our own previous studies (42, 
43), which enabled us to combine these data with the transcriptomic data generated here 
under the same experimental conditions. In the previous studies, HT-29 cells were exposed 
to IFNγ, which primes HT-29 cells to apoptose upon stimulation with TNF (48), and 
subsequently stimulated with saturating or subsaturating doses of TNF, EGF, or insulin alone 
or in combination. Lysates were profiled at 13 time points over 24 hours for 19 intracellular 
signaling events measured by kinase assay, immunoblot, or antibody array (Fig. 1, A and B) 
(49–51). These data provided quantitative, systematically collected information on 
phosphorylation-mediated regulatory events, changes in protein abundance, and cleavage-
dependent protein activation.
To determine how the signaling events altered gene expression, we complemented the 
signaling compendium with a matched set of transcriptomic profiles (Fig. 1A). IFNγ-
pretreated HT-29 cells were exposed to the same combinations of TNF-EGF-insulin and 
analyzed at a subset of the time points from the previous signaling studies (Fig. 1B). We 
collected transcriptomic profiles by microarray at intermediate-to-late times after cytokine 
simulation, thereby avoiding the bursts of immediate-early transcripts that are already well 
characterized (46, 47, 52). We selected the time points for transcriptomic analysis according 
to earlier modeling of the signaling compendium, which showed that signaling from 4 to 16 
hours did not predict apoptosis accurately (42). We reasoned that the loss of predictive 
ability was because prolonged cytokine stimulation had transmitted the relevant information 
to the downstream transcriptional network.
The microarray data revealed extensive transcriptional alterations with time and stimulus 
condition (Fig. 1C). Among 14,541 probe sets identified as present in at least one sample, 
we identified significant changes in 10,319 with time, 4948 upon TNF stimulation, 75 upon 
EGF stimulation, and 15 upon insulin stimulation after correction for multiple hypothesis 
testing [four-way analysis of variance (ANOVA), false -discovery rate = 5%; file S1]. One 
unanticipated complication was that many transcript abundances changed with time in the 
mock stimulation condition lacking TNF, EGF, and insulin (Fig. 1C, leftmost column). We 
attributed these background transcriptional dynamics to the ongoing IFNγ exposure. 
Extensive background drifts in transcript abundance can confound interpretations from 
standard analyses of differentially expressed genes that focus on time-dependent changes 
(53, 54). Therefore, alternative methods were required to identify meaningful changes in 
transcriptional regulation and link them to the upstream signaling network.
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 Models of dynamic, multivariate data sets are properly structured as data tensors
Systematic biology experiments monitor the same signaling events or transcripts over 
multiple time points and across multiple stimulus conditions (19, 55). Each data point thus 
contains information about the various “modes” of its acquisition, for example, which 
stimulus was added (mode 1), the time after stimulus (mode 2), and the signal or transcript 
measured (mode 3). Additional modes are possible if multiple pharmacologic perturbations 
(56, 57) or cell types (58) are profiled systematically along with the modes listed above.
For systematic measurements, the acquisition modes create a data structure that is very 
powerful mathematically because it conveys how different data points are related to one 
another. This structure vanishes when, for example, a data cube is sliced along one of its 
modes and “unfolded” end-to-end as a series of matrices (Fig. 2A). When matrix-based 
algorithms are applied to unfolded data, each unfolded measurement variable is treated 
independently, and modes 2 and greater are lost. Using Fig. 2A as an example, Akt 
measurements at 2 and 4 hours after stimulation (same signal, two time points) are not 
handled any differently than Akt and epidermal growth factor receptor (EGFR) 
measurements at 2 hours after stimulation (two signals, same time point). The result of 
unfolding is a model that is less interpretable because of too many fitted regression 
coefficients (59).
The alternative to unfolding is to retain data sets as cubes (three modes) or hypercubes (four 
or more modes) in the form of data “tensors” which are the higher-dimensional 
generalization of vectors (one mode) and matrices (two modes). For example, the TNF-
EGF-insulin signaling compendium naturally organizes as a third-order tensor defined by 
stimulus, time point, and measured signaling event (Fig. 2B). The transcriptomic profiles 
likewise arrange as a third-order tensor according to stimulus, time point, and transcript or 
cluster of transcripts (Fig. 2C). Tensors reduce the parameterization of a data-driven model 
because free regression coefficients remain fixed across the other acquisition modes of each 
tensor (Fig. 2B) (59, 60). In this instance, the stimulus–time point–signaling tensor (the 
“regressor” tensor) is linked to the stimulus–time point–transcript tensor (the “regressand” 
tensor) by the regression coefficients.
Biological data tensors have been used successfully for unsupervised purposes, such as 
singular value decomposition (27), to analyze transcriptional kinetics during DNA 
replication origin firing (28) and to identify consistent copy number changes across different 
array-based comparative genomic hybridization platforms (61). Here, we sought a 
supervised method that could connect the signaling tensor to the transcriptomic tensor and 
predict gene expression patterns from signaling network dynamics. This application is ideal 
for the tensor generalization of partial least squares regression (PLSR), a matrix 
implementation that has been used widely to model signaling networks (20, 25, 58, 62–76).
Tensor PLSR [equivalently, “multilinear PLS” (59)] is an established method that creates a 
data-driven model by jointly factorizing an independent “predictor” tensor (X; here, the 
signaling tensor) and a dependent “predicted” tensor (Y; the transcriptomic tensor). X and Y 
are factorized as an element-by-element product of vectors, where the number of vector 
elements multiplied is equal to the number of dimensions in the data tensor (text S1). Thus, 
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if X is a third-order tensor, then X(1,1,1) [the tensor element in X occupying the first 
position in mode 1 (stimulus), the first position in mode 2 (time point), and the first position 
in mode 3 (signal)] is factorized as: X(1,1,1) = t(1)• wj(1)•wk(1) (Fig. 2D, purple). In the 
factorization, t(1) is the first element of a “scores” vector (t) that relates to the stimulus 
conditions that are shared with the Y tensor. wj(1) and wk(1) are the first elements of two 
“weight” vectors (wj and wk) that relate to modes 2 and 3 of the tensor (here, time and 
signal). A similar calculation is performed for Y by factorizing it into its own scores (u) and 
weight (ql and qm) vectors. X and Y are linked by an “inner relationship” between their 
respective scores vectors: u = bt, where b is a linear regression coefficient determined by the 
model. The inner relationship implies that how a stimulus projects on t [through the 
signaling (wk) that occurs over time (wj)] is directly proportional to its projection on u and 
thus how that stimulus changes gene expression (qm) with time (ql).
The factorization of the two tensors is posed as a numerical optimization that seeks to 
capture as much of the inner relationship between X and Y as possible (details on the 
covariance maximization algorithm are described in text S1). The best first set of scores and 
weight vectors defines the first “latent variable” of the tensor PLSR model. Residual 
information (covariation) in X and Y not captured by the first latent variable is then 
subjected to a second factorization, which is optimized to capture as much covariance in the 
residual as possible (Fig. 2D). By repeating the algorithm, latent variables are iteratively 
calculated until there are no predictive inner relationships remaining between the X and Y 
data tensors (20, 62).
Predictions with a tensor PLSR model use wj and wk from each latent variable to project an 
X-like observation onto t (Fig. 2E). Then, the u = bt inner relationship is used to predict u, 
which is backprojected with ql and qm to yield a predicted set of values in the form of Y 
(time-dependent gene expression). The project-predict-backproject sequence is important for 
making independent predictions with new data and for cross-validation of the model to 
identify the optimum number of latent variables (20, 31, 62, 77).
 Tensor PLSR modeling identifies predictive links between signaling and transcriptional 
dynamics
We first constructed a tensor PLSR model of three latent variables that predicted the 14,541 
probe set fluorescence intensities of the transcriptomic data set. Although cross-validated 
predictions of the model were 99% accurate (fig. S1A), the model was strongly biased 
toward the differences in fluorescence intensities across probe sets. Consequently, changes 
in probe set intensities across treatment conditions were overlooked, and the resulting 
components of the model were uninterpretable (fig. S1, B to E). To focus on recurrent 
stimulus-dependent changes in transcript abundance shared by multiple genes, we 
condensed the transcriptomic data set by using the unbiased CLuster Identification via 
Connectivity Kernels (CLICK) algorithm (78). Among the transcripts profiled, CLICK 
identified nine separable clusters composed of dozens to hundreds of genes (file S2), the 
mean trajectories of which were organized as the Y data tensor (Fig. 2C). Using the entire 
signaling compendium as X, we constructed a tensor PLSR model of four latent variables 
that predicted gene -cluster dynamics to within 72% (Fig. 3A and fig. S2A). Although the 
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model did not predict certain cytokine-induced changes for some gene clusters (Fig. 3A, see 
EGF and insulin stimuli of cluster #3), we considered the overall accuracy of predictions 
remarkable considering that the model involved ~10-fold fewer parameters than previous 
PLSR models of TNF-induced apoptosis (42, 62, 64).
Our principal motivation for building the tensor PLSR model was to use the model to reveal 
undiscovered mechanisms of how signaling alters gene expression. To identify which latent 
variables captured both signaling and gene -cluster dynamics, we analyzed the time weights 
(wj and ql) and inner regression coefficients for X and Y (Fig. 3B). The leading two latent 
variables (LV#1 and LV#2) harbored signaling time weights (wj1 and wj2) that were nearly 
constant from 0 to 24 hours, indicating that time-dependent changes in signaling did not 
determine the projection of X along LV#1 or LV#2. Accordingly, time weights for the gene 
clusters (ql1 and ql2) were time-variant and derived from the stimulus-independent 
transcriptional changes of clusters #1, #2, and #7 (Fig. 3, A and B), presumably resulting 
from IFNγ pretreatment. Because latent variables are calculated iteratively (Fig. 2D), LV#1 
and LV#2 eliminated the TNF-, EGF-, and insulin-independent transcriptional changes, 
revealing paired signaling and gene -cluster dynamics in the third and fourth latent variables 
(LV#3 and LV#4). LV#3 harbored time weights of late-phase signaling (wk3) and sustained 
transcriptional activation (ql3). Conversely, LV#4 was weighted with early-phase signaling 
(wk4) and late-phase transcriptional regulation (ql4). The inner regression coefficient for 
LV#4 was negative (Fig. 3B, orange), implying a link between early-phase signaling and 
downstream transcriptional repression.
Focusing on LV#3 and LV#4, we evaluated the relationship between the treatment scores (t3 
and t4; Fig. 3C). Relative to mock treatment, saturating TNF stimulation projected almost 
entirely along LV#3, suggesting that LV#3 represented a TNF “axis” In contrast to TNF, we 
found that EGF and insulin projected in opposite directions along LV#4, indicating that this 
latent variable distinguished between the two growth -factor stimuli. Combinatorial 
stimulations exhibited intermediate scores that approximately averaged the scores of the 
individual stimuli. For example, TNF+EGF projected positively along LV#3 (like TNF) and 
negatively along LV#4 (like EGF). The interpolated response observed here for gene 
regulation contrasts with previous work on apoptosis in which EGF and insulin each 
nonlinearly antagonized TNF-induced cell death (62).
To connect specific signals and gene clusters with the prevalent cytokine-induced dynamics, 
we evaluated the signaling and gene -cluster weights along LV#3 (TNF; late-phase signaling 
axis: wk3 and qm3) and LV#4 (EGF-insulin; early-phase signaling axis: wj4 and qm4) (Fig. 3, 
D and E). Multiple signals, such as Ser636-phosphorylated insulin receptor substrate-1 
[pIRS1 (Ser636)], c-Jun N-terminal kinase (JNK) activity, and mitogen-activated protein 
kinase (MAPK)–activated protein kinase-2 (MK2) activity, were negligibly weighted (Fig. 
3D), implying that these early-phase TNF-induced signals (Fig. 1B) were statistically 
uninformative for predicting Y (the transcriptional response). Gene cluster #1 was also 
unweighted along LV#3 and LV#4, because its dynamics were almost entirely captured by 
LV#1 and LV#2 (Fig. 3, A, B, and E, and fig. S2B). To filter the weight vectors further, we 
randomly shuffled the signaling, gene -cluster, and time information within each cytokine 
stimulation (mode 1 slice) of X and Y (79). With hundreds of shuffled tensor PLSR models, 
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we estimated a null projection for the weight vectors of LV#3 and LV#4 (Fig. 3, D and E, 
gray line). We considered signals and gene clusters outside 1 SD (σ, gray dashed lines) of 
the null projection as weighted strongly enough to warrant further analysis (Fig. 3, D and E).
Among the strongest signaling weights, we found clear agreement with known mechanisms 
of signal transduction (Fig. 3D). For example, cleavage of apoptotic caspases [negative 
weighting for procaspase-8 and procaspase-3 and positive weighting of cleaved caspase-8] 
was strongly aligned along LV#3, which is consistent with late-phase caspase activation 
triggered by TNF (48, 80). Along LV#4, insulin stimulation coincided with positive weights 
for three complementary measures of Akt activation, a recognized effector pathway (81). 
Likewise, multiple measures of EGFR phosphorylation were weighted in a direction that 
corresponded to EGF stimulation. Also strongly associated with EGF signaling was 
phosphorylated insulin receptor substrate-1 [pIRS1 (Tyr896)], consistent with reports that 
this site may be directly phosphorylated by active EGFR (42, 82). Not all signaling events 
were associated with individual stimuli. For instance, the weights associated with inhibitor 
of nuclear factor-κB kinase (IKK) activation mapped not only to TNF but also to insulin 
stimulation, possibly because Akt signaling can activate IKK in certain contexts (83, 84). 
Similarly, phospho-EGFR (Tyr1068) projected with early-phase EGF and also late-phase 
TNF signaling. The latter is probably due to autocrine signaling by transforming growth 
factor-α, an EGFR ligand that is released after TNF stimulation (43, 85). Together, the 
weights of LV#3 and LV#4 provided a condensed map of the signaling compendium that 
was optimized for predicting the observed transcriptomic profiles.
The inner regression coefficient (b3) connecting X and Y along LV#3 was a positive value, 
indicating gene activation, whereas the inner regression coefficient b4 was negative, 
indicating that signaling along LV#4 resulted in gene repression (Fig. 3, B and E). Contrary 
to that of the signaling compendium, the projection of gene clusters along LV#3 and LV#4 
was surprising (Fig. 3E). Amidst thousands of time-dependent transcriptional changes, few 
clusters were weighted toward specific stimuli. Clusters #3 and #6 were primarily weighted 
along LV#3, indicating an association with TNF stimulation. Accordingly, promoter analysis 
(86) of the transcripts in these two clusters revealed a strong overrepresentation of binding 
sites for nuclear factor κB (NF-κB) (fig. S2C). Cluster #7 mapped along LV#4 because of 
the mild suppression of transcripts observed with saturating insulin alone (Fig. 3, A and E). 
Only cluster #9 projected strongly along both latent variables, indicating that the transcripts 
in this cluster were induced by TNF and repressed by insulin (fig. S3). TNF antagonism of 
insulin function has been well documented in adipocytes (87, 88), but there are few reports 
of insulin antagonizing TNF (89). Given this predicted TNF and insulin “crosstalk cluster” 
we used the tensor PLSR model to investigate its mechanism of regulation by the upstream 
signaling network.
With respect to its latent variable projections, cluster #9 was cartographically most similar to 
IKK (Fig. 3, D and E). If these shared projections were indicative of mechanism, however, it 
would imply that early-phase IKK activity (downstream of TNF and insulin signaling) 
represses transcription of the crosstalk cluster, whereas late-phase IKK (downstream of TNF 
signaling) promotes it. Repress-then-activate kinetics are opposite of the prevailing view of 
IKK signaling (90). Accordingly, we found that TNF-induced responses of 85% of 
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transcripts in cluster #9 were not significantly affected when a phosphorylation- and 
degradation-resistant mutant of IκBα was ectopically expressed in HT-29 cells (log-
transformed Welch’s t test, false discovery rate = 15%; fig. S4). We therefore considered 
alternatives that were consistent with the tensor PLSR model.
One possible explanation was that the crosstalk cluster integrated two distinct signaling 
inputs. An activating input could arise from a TNF-specific signal that was either not 
measured or not projected strongly on LV#3 and LV#4. In parallel, the cluster could be 
transcriptionally inhibited by an insulin-specific signal, such as Akt (Fig. 3D), or a 
downstream effector pathway of Akt (91).
 Promoter and signaling bioinformatics suggest a link between GSK3 and the crosstalk 
cluster through GATA6
First, we determined the reliability and generality of TNF-insulin crosstalk among 
transcripts in cluster #9. We repeated the stimulation experiments with an independently 
obtained vial of HT-29 cells and assayed individual transcripts by quantitative reverse 
transcription polymerase chain reaction (qRT-PCR). This analysis confirmed the expression 
of more than 90% of the 22 cluster #9 transcripts (SPRR1B and PPARD from fig. S3 were 
false positives), and we detected an antagonistic interaction between TNF and insulin from 2 
to 8 hours after stimulation (fig. S5). At individual time points for specific genes, we 
observed instances of antagonism represented by significant interaction P value (Pint < 0.05, 
two-way ANOVA; Fig. 4, A and B), an indication that TNF and insulin have nonadditive 
effects on the expression of those genes. We also observed nonlinear significant differences 
in gene expression for other transcripts even when the Pint was not significantly different 
(Fig. 4, C and D). The qRT-PCR data thus confirmed the microarray results and the tensor 
PLSR model, showing an early-phase suppression of TNF-induced cluster #9 genes by 
insulin (Fig. 3, B to E). Furthermore, these data indicated that the TNF-insulin crosstalk 
cannot be predicted by adding the effect of insulin to the TNF response.
To identify candidate mediators of TNF-insulin crosstalk, we analyzed the expression-
verified transcripts of cluster #9 with three orthogonal promoter -analysis algorithms (86, 92, 
93). Only two transcription factors were suggested as candidate regulators by all three 
algorithms: T cell factor 4 (TCF4) and GATA (Fig. 4E). HT-29 cells harbor a truncating 
mutation in APC (adenomatous polyposis coli), a protein that inhibits the β-catenin pathway, 
and this truncation renders β-catenin and its transcriptional partner TCF4 constitutively 
active (94). Moreover, no changes in β-catenin localization were observed upon TNF 
simulation with or without insulin (fig. S6). Therefore, we focused on GATA, a family of six 
transcription factors that are important for development and differentiation (95). Using qRT-
PCR (96, 97), we quantified the relative copy numbers of the GATA family and found that 
GATA6 was the most abundant isoform (Fig. 4F and fig. S7). Copies of GATA6 transcript 
also remained high during the early phase of TNF-only and TNF + insulin stimulation, 
whereas GATA2 and GATA3 were reduced two- to fourfold (Fig. 4, G to I). Notably, 
bioinformatic analysis (98) of the full-length GATA6 protein sequence uncovered a cluster 
of highly conserved serine residues that were candidate phosphorylation sites for GSK3 
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(Fig. 4J). Because GSK3 is a recognized substrate of Akt (81), these results suggested that 
GATA6 could be an insulin-dependent regulator of the crosstalk cluster.
Full-length GATA6 (GATA6L) is distinguished by a long N-terminal extension that is 
conserved across vertebrates but missing in other GATA family members (fig. S8). In 
addition, leaky ribosome scanning (99) onto an in-frame methionine (Met147) gives rise to a 
short form of GATA6 (GATA6S) that is comparable in size (~45 kD) to the other GATA 
isoforms. GATA6S lacks the candidate GSK3 phosphorylation sites that reside at the N 
terminus of GATA6L (Fig. 4J), raising the possibility of selective regulation of GATA6L by 
insulin.
Compared to GATA6S, GATA6L has been understudied because of early misannotations of 
nonhuman genomes and a lack of suitable reagents. Common plasmid repositories, including 
Addgene (100), the human ORFeome (101), and the Mammalian Gene Collection (102), 
have only the short form or lack the gene entirely. The unusually slow electrophoretic 
mobility of GATA6 has created additional confusion because commercial antibody vendors 
mistakenly label GATA6S as “GATA6” implying that the detected protein is the full-length 
form. As a result, the GATA6 literature is incredibly ambiguous, with many papers 
inadvertently focusing on GATA6S.
To determine whether the predicted GSK3 phosphorylation sites of GATA6L could be 
phosphorylated in HT-29 cells, we cloned the full-length gene with N-terminal FLAG and C-
terminal AU1 tags into a doxycycline inducible lentivector (see Materials and Methods) 
(103). Stable HT-29 transductants were induced with doxycycline for 24 hours before lysis, 
and FLAG immunoprecipitates were subjected to phosphorylation analysis by mass 
spectrometry. We achieved 92% coverage of the GATA6L sequence and identified 11 
phosphorylation sites, including 7 that had not been previously reported (Fig. 4K) (104). 
Among sites in the N-terminal extension specific to GATA6L, two (Ser33 and Ser37) were 
consistent with the bioinformatic predictions of GSK3 phosphorylation (Fig. 4J). Two N-
terminal sites (Thr34 and Ser37) were also corroborated by a proteomics study of proline-
directed phosphorylation in 293T cells (105). We concluded that Ser33, Thr34, and Ser37 
were the leading candidates for GATA6L phosphorylation–mediated regulation by GSK3.
 Perturbation of basophilic kinases differentially affects GATA6L and GATA6S
Studies of GATA6 phosphorylation have largely focused on its posttranslational regulation 
by MAPKs (106–108). However, GATA6 is reportedly phosphorylated on Ser436 (Ser290 in 
GATA6S) and stabilized upon prolonged mechanistic target of rapamycin complex 1 
(mTORC1) inhibition with rapamycin and subsequent feedback activation of Akt2 in 
vascular smooth muscle cells (VSMCs) (109). Our mass spectrometry data on GATA6L did 
not include peptides containing Ser436; thus, we could not rule out a role for Akt as a 
GATA6 kinase activated by insulin stimulation.
To determine whether Akt-catalyzed stabilization of GATA6 was relevant to our study, we 
treated HT-29 cells with the mTORC1 inhibitor rapamycin for 3 hours and monitored targets 
by quantitative immunoblotting (51). As expected, rapamycin eliminated phosphorylation of 
ribosomal protein S6 and increased phosphorylation of Akt by about twofold; however, the 
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abundances of GATA6S and GATA6L were essentially unchanged (Fig. 5A). In the context 
of IFNγ pretreatment and TNF-insulin stimulation, we found that rapamycin treatment for 3 
hours altered the distribution of GATA6 forms by decreasing the abundance of GATA6L 
relative to the abundance of GATA6S (fig. S9). The mechanism reported in VSMCs (109) 
might be restricted to mesodermal tissues, so we repeated the experiment in AC16 
ventricular cardiomyocytes (110). In these cells, S6 phosphorylation disappeared without 
subsequent feedback activation of Akt, and yet, GATA6S abundance increased modestly 
after 3 hours as reported in VSMCs (Fig. 5B) (109). Critically, under the same conditions in 
AC16 cells, we did not observe any alterations in the abundance of GATA6L. These 
experiments illustrated that Akt feedback activation could be uncoupled from GATA6 
stabilization, as could the posttranslational regulation of its long and short forms.
 GSK3-dependent phosphorylation of Ser37 accelerates GATA6L turnover
To assess the importance of the GATA6L phosphorylation sites, we transfected single alanine 
mutants of Ser33, Thr34, and Ser37 or the triple mutant (3×SA) into 293T cells, cells in 
which GATA6L phosphorylation has been detected previously (105). Compared to the wild-
type allele, we noted a pronounced electrophoretic downshift in the major FLAG-
immunoreactive band of the Ser37 and 3×SA mutants (Fig. 6A). The mobility shift was 
larger than that expected for a single phosphorylation site, suggesting that Ser37 
phosphorylation was required for other phosphorylation events within GATA6L. Iterative 
phosphorylation-dependent phosphorylation is characteristic of many GSK3 substrates, such 
as glycogen synthase (GS) (111).
Careful inspection of endogenous GATA6L immunoreactivity in HT-29 extracts revealed a 
slower migrating species that was similar to the electrophoretic shifts observed in 293T cells 
transfected with the phosphorylation-deficient mutants. We isolated this species from the 
faster migrating GATA6L through Phos-tag electrophoresis (112) followed by Gaussian 
mixture modeling of the densitometric traces (see Materials and Methods). Acute TNF 
treatment reduced the upper form of GATA6L but with a concomitant increase in the lower 
form, such that total GATA6L abundance was not altered (Fig. 6B). Costimulation with 
insulin or pretreatment with the GSK3 inhibitor CT99021 (113) did not alter the GATA6L 
downshift, despite insulin increasing GSK3 phosphorylation and CT99021 decreasing GSK3 
activity (Fig. 6, C and D, and fig. S10). Because GATA6 mRNA was not induced by TNF 
(Fig. 4I), these results indicated that GATA6L is dephosphorylated on some residues in 
response to TNF stimulation.
Our next goal was to evaluate the specific impact of Ser37 phosphorylation on GATA6L in 
HT-29 cells. One challenge was that the endogenous abundance of GATA6S was high 
compared to GATA6L (Fig. 5A), which could confound interpretations of ectopically 
expressed proteins. Therefore, we inducibly knocked down endogenous GATA6 with short 
hairpin RNA and added back epitope-tagged versions of wild-type or S37A GATA6L so that 
the abundance was comparable to total endogenous GATA6 (Fig. 6, E and F; see Materials 
and Methods). Doxycycline-induced addback in HT-29 cells recapitulated the 
electrophoretic mobilities of GATA6L that were observed in transfected 293T cells. The data 
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suggested that the GATA6L modifications are not artifacts of overexpression, enabling use of 
the addback cells to examine the consequences of Ser37 phosphorylation.
Because GSK3 phosphorylation often accelerates substrate turnover (114), we combined the 
Phos- tag analysis with the HT-29 addback lines to estimate half-lives of wild-type and 
S37A GATA6L. We combined inhibition of protein synthesis with TNF stimulation to enrich 
for the lower migrating form of wild-type GATA6L in the addback cells. Under these 
conditions, we found that the half-life of more phosphorylated GATA6L was more than 
twice that of the wild-type GATA6L form that was less phosphorylated (Fig. 6, G and H). 
Surprisingly, the half-life of the S37A mutant was comparable to that of the more 
phosphorylated form of GATA6L, suggesting that phosphorylation of Ser37 without 
subsequent additional phosphorylation renders GATA6L unstable. Ser37 resides in the 
middle of a proline-glutamate-serine-threonine (PEST) degradation motif of GATA6L, and 
this motif scores more strongly as a PEST motif than those in other well-known unstable 
proteins (Fig. 4J and table S1) (115, 116). Ser37 phosphorylation might activate or expose 
the PEST sequence for rapid proteolytic degradation of GATA6L, whereas additional 
phosphorylation at other sites could inhibit substrate recognition (115).
To monitor Ser37 phosphorylation specifically, we raised and affinity-purified a phospho-
specific antibody against a monophosphorylated peptide fragment of the PEST sequence in 
GATA6L (see Materials and Methods; fig. S11). If Ser37 modification were a prerequisite for 
subsequent phosphorylation, then the antibody would capture this initial phosphorylation 
event of GATA6L, with the caveat that phosphorylation on Ser33 and Thr34 would ultimately 
disrupt the antibody epitope. To evaluate the phospho-Ser37 antibody, we reassessed the 
immunoreactivity of total GATA6. The predicted molecular weights of GATA6S and 
GATA6L are 45.4 and 60 kD, respectively. However, extensive posttranslational 
modifications (Fig. 4K) cause most GATA6S and GATA6L to run at an apparent molecular 
weight of ~54 kD and ~69 to 75 kD depending on electrophoresis conditions (Fig. 7A). 
Multiply phosphorylated GATA6S (~54 kD) can be misinterpreted as unmodified GATA6L 
(60 kD). Upon long exposure with a total GATA6 antibody, we revealed an additional 
immunoreactive band at ~60 kD that was eliminated by GATA6 knockdown and 
reconstituted with addback of wild-type GATA6L and the S37A mutant (Fig. 7A). In contrast 
to the 75-kD form (Fig. 6E), the ~60-kD form of wild-type GATA6L was significantly less 
abundant than the S37A mutant (Fig. 7B), consistent with decreased stability. We interpreted 
the ~60-kD band as the unmodified form of GATA6L.
Endogenous Ser37 phosphorylation of the 75 and 60-kD GATA6L forms was not detectably 
altered in response to TNF treatment for 1 hour or CT99021 treatment for 6 hours (Fig. 7, C 
and D). However, the endogenous 60-kD phospho-GATA6L signal was barely above the 
detection limit and thus highly variable (coefficient of variation, ~40%), yielding only ~50% 
statistical power for detecting a 1.5-fold change. To evaluate phosphorylation of endogenous 
GATA6L on Ser37, we serum- starved the HT-29 cells to produce a stronger activation of 
GSK3 and confirmed specificity of the phosphorylation events with CT99021 pretreatment 
for 1 hour (Fig. 7, E and F). As expected, serum starvation reduced GSK3 phosphorylation 
(increasing GSK3 activity) and increased phosphorylation of GS (Fig. 7F). CT99021 
reduced GS phosphorylation and total GSK3 abundance but also transiently increased total 
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GS. Notably, within 1 hour of serum withdrawal, we observed a robust increase in the 60-kD 
form of phospho-GATA6L, which coincided with the timing of GSK3 dephosphorylation 
and was blocked by CT99021 in a dose-dependent manner (Fig. 7E and fig. S12). By 
contrast, phospho-Ser37 immunoreactivity of the 75-kD form of GATA6L was not altered by 
serum starvation or CT99021 treatment, suggesting that Ser37 was already stably 
phosphorylated in this form of GATA6L.
Total abundances of the different forms of GATA6L also showed dynamic changes. GATA6L 
at 75 kD and GATA6S decreased significantly with CT99021 treatment, whereas GATA6L at 
60 kD increased compared to uninhibited control cells that were serum-starved (P < 0.05, 
two-way ANOVA). The time-dependent changes in 60-kD GATA6L abundance mirrored the 
changes in total GS and inversely correlated with changes in 60-kD GATA6L 
phosphorylation at Ser37 (Fig. 7, E and F). These experiments provide further evidence that 
Ser37 is a site phosphorylated by GSK3 and that phosphorylation at this site promotes 
turnover of GATA6L in the absence of phosphorylation at additional sites.
With greater confidence in the phospho-GATA6L (Ser37) antibody, we revisited the original 
biological context of IFNγ-pretreated HT-29 cells stimulated with TNF and insulin. To 
enable detection, we immunoprecipitated cell extracts with phospho-GATA6L (Ser37) 
antisera and immunoblotted for total GATA6 (Fig. 7G). An extended electrophoresis was 
required to separate the 60-kD form from the heavy chain of the immunoprecipitating 
antibody, causing a smear of immunoreactivity rather than a discrete band (see Materials and 
Methods). In response to TNF alone, we repeatedly observed a drop in 75-kD, but not 60-
kD, GATA6L phosphorylation (Fig. 7H), corroborating the dephosphorylation previously 
noted by Phos-tag electrophoresis (Fig. 6B). Moreover, the reduction in 75-kD phospho-
GATA6L (Ser37) was blocked by insulin costimulation, indicating a specific point of 
crosstalk between TNF and insulin. Insulin, by contrast, independently elevated the 
abundance of 60-kD GATA6L phosphorylation, suggesting that insulin delays the turnover of 
this form beyond its effect on Ser37 phosphorylation. We conclude that the phosphorylation 
of endogenous GATA6L at Ser37 is consistent with the antagonism and linear superposition 
in abundance of cluster #9 transcripts observed upon TNF + insulin stimulation (Fig. 4, A to 
D, and fig. S5).
 GSK3-dependent phosphorylation of Ser37 alleviates GATA6L repression of transcripts 
in the crosstalk cluster
We investigated the role of GATA6L phosphorylation in the regulation of transcripts 
subjected to TNF-insulin crosstalk. We inducibly overexpressed wild-type GATA6L in 
HT-29 cells (Fig. 8A) before stimulation with TNF for 2 hours and transcriptomic profiling 
by microarray (see Materials and Methods). GATA6 can act as either a transcriptional 
activator or repressor (117), but we found that, in the GATA6L-overexpressing HT-29 cells, 
the effects of GATA6L were predominantly repressive. Without stimulation, GATA6L 
overexpression induced 51 transcripts and repressed 136 transcripts at a 5% false -discovery 
rate (P < 10−10, binomial test) (file S4). TNF stimulation increased the number of genes 
affected by GATA6L overexpression, but the bias toward repression persisted (317 induced 
transcripts versus 438 repressed transcripts; P < 10−5, binomial test) (file S4). Notably, the 
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same repressive bias was observed for transcripts in the crosstalk cluster (Fig. 8B), and those 
with the strongest GATA6L-associated repression were among the clearest examples of 
TNF-insulin crosstalk (Fig. 4, A to C). Using chromatin immunoprecipitation (ChIP), we 
confirmed binding of GATA6L to consensus sites within the promoters of many TNF-insulin 
crosstalk genes (fig. S13), suggesting that repression is direct.
If GATA6L mediates the insulin-stimulated repression of the crosstalk cluster and is 
stabilized by inhibition of the GSK3 pathway, then phosphorylation of Ser37 would provide 
a mechanism for TNF-insulin crosstalk. Furthermore, the S37A mutant of GATA6L should 
mimic the effect of insulin on TNF-stimulated gene expression for transcripts in the 
crosstalk cluster and dampen the crosstalk observed when insulin is added to S37A mutant 
cells. We tested this prediction with the wild-type and S37A addback lines (Fig. 6, E and F), 
inducing GATA6L and then stimulating with TNF, insulin, or both. By qRT-PCR, we 
identified multiple instances in which S37A addback reduced transcript abundance similar to 
that observed in wild-type addback cells stimulated with insulin (Fig. 8C, green). We also 
found many examples in which TNF + insulin–induced transcript abundance was higher in 
S37A addback cells compared to wild-type addback cells (Fig. 8C, purple) and more similar 
to TNF-treated cells, suggesting reduced crosstalk. Analysis of the entire cluster #9 data set 
revealed significant interactions between GATA6 and TNF or insulin (interaction P < 10−3, 
five-way ANOVA), indicating that the Ser37 genotype alters the transcriptional response to 
both stimuli. Together, our data support a model whereby TNF promotes and insulin inhibits 
the formation and degradation of GATA6L monophosphorylated on Ser37 (Fig. 8D). This 
phosphoregulation is ultimately reflected by the abundance of transcripts in the crosstalk 
cluster.
 Ser37 phosphorylation of different GATA6L forms is observed in diverse cell types
The model of GATA6L phosphorylation–mediated regulation (Fig. 8D) may be specific to 
HT-29 cells or could occur in other cell types. We immunoblotted various cell lines with the 
phospho-Ser37 antibody in comparison to affinity-purified antisera binding the 
nonphosphorylated peptide surrounding Ser37 (see Materials and Methods) and to other 
commercial GATA6 antibodies (100, 118). In HCT-8 and DLD-1 colorectal cancer lines, 
AC16 cardiomyocytes (110), and MCF10A-5E breast epithelial cells (119), we observed the 
60 and 75-kD forms of GATA6L, which were phosphorylated to variable extents according 
to phospho-Ser37 immunoreactivity (Fig. 9, A and B). Multiple GATA6 antibodies also 
recognized another species at ~100 kD (Fig. 9, A to D), suggesting that an even more 
phosphorylated form of GATA6L may remain to be characterized. The aggregate number of 
reported phosphorylation sites on GATA6L now exceeds 20 (Fig. 4K).
 DISCUSSION
Our study here introduces and implements tensor PLSR as an approach for structured 
biological data sets. Considering that signaling dynamics often occur in discrete temporal 
phases (49, 80, 120, 121), tensor PLSR provides an attractive means to deconstruct time -
course data in a systematic manner. Although the mathematics has been established for 
decades (59), data types that can exploit the tensor framework are relatively new to cell 
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signaling. For tensor generation, a multiplex technique that simply measures many genes or 
proteins is insufficient. The method must also be cost-effective, reproducible, and scalable 
for repeated use across multiple treatments, time points, and perturbations. The newest 
technologies rarely meet these criteria, prompting our use of long-established methods at a 
scale not typically considered.
We applied tensor PLSR with the goal of discovering molecular mechanisms that connect 
signaling to transcriptional regulation. Ideally, the mechanisms would involve proteins not 
originally included in the systematic data set. Systems-level studies rarely uncover these 
“hidden nodes” and validate them experimentally like we achieved here for GATA6L (25, 
122). Testing model- or bioinformatics-derived predictions requires a skill set entirely 
different from the one needed to perform the analysis. Our findings argue for the benefits of 
dual training, where computationalists work at the bench and experimentalists use 
quantitative models, gaining an appreciation for the thematic similarities in each approach. 
For example, just as modeling assumptions should be subjected to falsification (31), we 
sought to challenge the prevailing biological assumptions about GATA6 and its different 
forms.
The deceptive electrophoretic mobilities of GATA6S and GATA6L have important 
implications for biological function. Although GATA6L is generally less abundant than 
GATA6S in most cell types, there is evidence that GATA6L is the more potent transcriptional 
regulator (99). GATA6 promotes the expression of the stem cell marker LGR5 in colorectal 
cancer (118, 123). Neither paper clarified whether the regulation occurs through GATA6L, 
GATA6S, or both. However, insulin-like growth factor inhibits GSK3 and promotes 
expansion of Lgr5+ stem cells in mice (81, 124). Our results indicate that one mechanism for 
this expansion is the stabilization of GATA6L.
The phosphorylation of Ser37 adds a GATA6L-specific mode of regulation to reports of 
posttranslational modifications that would presumably target both long and short forms 
(107–109). Although we were unable to reproduce the mechanism exactly (109), 
modification of Ser436 by Akt2 should coincide with the loss of Ser37 phosphorylation to 
stabilize GATA6L synergistically in contexts where both pathways operate. GATA6L 
phosphorylation–mediated regulation could prove important in endothelial cells, a TNF- and 
insulin-responsive cell type in which GSK3 and GATA6 interact as a complex (125). Our 
mass spectrometry study also uncovered other GATA6L-specific proline-directed 
modification sites (Thr62 and Ser137) that could function with the Ser266 site phosphorylated 
by extracellular signal–regulated kinase (ERK) (107, 108). Such complex layers of 
regulation should be expected of a transcription factor that is central to embryonic 
development and cell specification (95).
By coupling systematic experiments with statistical modeling approaches, such as tensor 
PLSR, one can identify relationships that would otherwise go unnoticed. Although it 
remains atypical to collect transcriptomic data as tensors, we expect widespread 
systematization of transcriptomics as expression -profiling costs drop. A model is just the 
first step, however, because the most surprising data-derived connections will require the 
identification of previously unrecognized mechanisms to explain them. These, in turn, 
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require hypothesis-driven experiments with the best molecular -genetic and pharmacologic 
perturbations available. For understanding how gene expression is controlled by complex 
stimuli, the integration of molecular biology and systems biology has yet to be fully 
exploited.
 MATERIALS AND METHODS
 Cell culture
HT-29, 293T, DLD-1, and HCT-8 cells were obtained from the American Type Culture 
Collection (ATCC) and cultured according to their recommendations. The 5E clone of 
MCF10A cells was cultured as described previously (119). AC16 cells (110) were purchased 
from M. Davidson (Columbia University) and cultured in Dulbecco’s modified Eagle’s 
medium/F-12 medium (Life Technologies) with 12.5% tetracycline-free fetal bovine serum 
(Clontech) and penicillin-streptomycin (Gibco).
 Cell stimulation
HT-29 cells were plated at 50,000 cells/cm2 for 24 hours, sensitized with human IFNγ (200 
U/ml) for 24 hours (Roche), and then treated with TNF (100 ng/ml; PeproTech), insulin (500 
ng/ml; Sigma), or both for the indicated times. HT-29 cells engineered to express GATA6L 
inducibly were treated with doxycycline (1 μg/ml) for 24 hours (overexpression) or 48 hours 
(addback) before cytokine stimulation.
 Plasmids
Wild-type GATA6L was amplified by PCR from HT-29 RNA that had been reverse-
transcribed with a GATA6-specific primer (CAAAAGCAGACACGAGTGGA). An N-
terminal 3×FLAG tag and a C-terminal 3×AU1 tag were added by PCR before cloning into 
the Bam HI and Sal I sites of pBabe puro (126) or the Mfe I and Spe I sites of 
pEN_TTmiRc2 (103). The pEN_TT donor vector containing GATA6L was then recombined 
with the pSLIK Neo destination vector (103) by using LR Clonase (Invitrogen). The 
shGATA6 sequence (CCCAGACCACTTGCTATGAAA; #TRCN0000005390 from the 
RNAi Consortium) was cloned into tet-pLKO-puro (127) as described previously (97). 
S33A, T34A, S37A, and 3×SA point mutants were prepared by site-directed mutagenesis 
(QuikChange II XL, Agilent). RNA interference–resistant mutants of wild-type and S37A 
GATA6L were prepared by introducing four silent mutations into the sequence targeted by 
shGATA6, which were replaced with rare mammalian codons that would minimize ectopic 
expression. The phosphorylation- and degradation-resistant IκBα super-repressor plasmid 
has been previously described (128). All DNA constructs were verified by sequencing.
 Production and purification of phospho-GATA6L (Ser37) antibody
The peptide sequence Ac-CREPSTPPpSPIS-amide was conjugated to keyhole limpet 
hemocyanin and used to immunize rabbits according to the manufacturer’s 
recommendations (Covance). Serum samples were tested by immunoblotting with positive 
and negative controls for phospho-GATA6L (Ser37). Serum pooled from the production and 
terminal bleeds was negatively selected on a CREPSTPPpSPIS peptide–conjugated N-
hydroxysuccinimide (NHS)–Sepharose column. The bound immunoglobulin G (IgG) was 
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eluted as the non–phospho-GATA6L custom antibody while the flow through was exposed to 
a second CREPSTPPpSPIS peptide–conjugated NHS Sepharose column. The bound IgG 
was eluted as the phospho-GATA6L (Ser37) antibody and used for detection by 
immunoblotting.
 Lentiviral packaging and transduction
Lentiviruses were prepared in human embryonic kidney (HEK) 293T cells (ATCC) by 
calcium phosphate transfection of the lentivector together with psPAX2 and pMD.2G 
(Addgene). Lentiviral transduction of HT-29 cells was performed as described previously 
(96). Transduced cells were selected in growth medium containing 2 puromycin (2 μg/ml) or 
G418 (600 μg/ml) until control plates had cleared. For addback experiments, viral titers were 
reduced to ensure single-virion transductants that matched the endogenous protein 
abundance as closely as possible.
 Microarray profiling
HT-29 cells were plated at 50,000 cells/cm2 for 24 hours and sensitized with IFNγ (200 
U/ml; Roche) for 24 hours before stimulation with TNF (0, 5, or 100 ng/ml), EGF (0, 1, or 
100 ng/ml), and insulin (0, 5, or 500 ng/ml) for 4, 8, or 16 hours. RNA isolation was 
performed with the RNeasy Mini Kit (Qiagen), and integrity of purified RNA was confirmed 
on a Bioanalyzer (Agilent). Preparation of labeled complementary RNA, hybridization to 
GeneChip Human Genome U133A Arrays (Affymetrix), microarray scanning, and 
microarray processing were performed as previously described (129).
For inducible GATA6L overexpression, stably transduced HT-29 cells were plated at 50,000 
cells/cm2 for 24 hours, induced with doxycycline (1 μg/ml), and sensitized with IFNγ (200 
U/ml Roche) for 24 hours before stimulation with TNF (100 ng/ml) for 2 hours. RNA was 
purified as described above and amplified with the Illumina TotalPrep-96 RNA 
Amplification Kit (Life Technologies) before hybridization to a HumanHT-12 v4 Expression 
BeadChip.
 Hierarchical and CLICK clustering
One-way hierarchical clustering of the signaling and transcriptomic compendia was 
performed in MATLAB with the clustergram function using Euclidean distance and Ward’s 
linkage after row standardization. CLICK clustering was performed as described (78) with 
the default homogeneity parameter.
 Tensor PLSR
Tensor PLSR was performed in MATLAB with version 2.02 of the NPLS Toolbox (130). 
The signaling compendium was structured by stimulus condition (mode 1), time point (mode 
2), and measured signal (mode 3). The transcriptomic profiles were structured by stimulus 
condition (mode 1), time point (mode 2), and CLICK gene cluster (mode 3). Both data 
tensors were mean-centered along mode 1 and variance-scaled along modes 2 and 3 before 
calculation of latent variables (131). The scores and time weights of LV#4 of the signaling 
tensor were both multiplied by –1 to improve model interpretability. Randomized models 
were constructed in MATLAB with the shuffle matrix function applied within each stimulus 
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condition before preprocessing and calculation of latent variables. The code for the tensor 
PLSR models is included in file S3.
 Bioinformatic analyses of crosstalk cluster
The 20 transcripts from cluster #9 confirmed present by qRT-PCR were submitted to three 
promoter analysis algorithms. First, the proximal promoter of each transcript [defined as 
2000 base pairs (bp) upstream and 500 bp downstream of the transcription start site] was 
collected from National Center for Biotechnology Information (NCBI) and used as an input 
set for MEME, which uses expectation maximization to define recurrent motifs in a set of 
sequences (132). The top five enriched motifs were searched against a database of 843 
binding specificities (133) using TOMTOM (134) to identify known transcription factor 
recognition sequences. A GATA motif was also enriched when using 2000 bp of upstream 
sequence alone or 1500 bp of upstream sequence and 500 bp of downstream sequence.
Expression-verified cluster #9 transcripts were additionally analyzed with DiRE (86), which 
uses interspecies sequence conservation to define motifs that are searched against the 
TRANSFAC 10.2 database of roughly 400 transcription factor binding motifs. In DiRE, the 
occurrence metric reflects the overall frequency of a conserved binding motif in the input 
data set, whereas the importance metric reflects the specificity of the binding motif to the 
input data set compared to a background data set of 5000 randomly selected genes. The top 
20 motifs based on occurrence were used as the DiRE predictions.
Last, X2K (92) was used to identify bioinformatic connections between cluster #9 
transcripts and signaling pathways. X2K integrates the ChEA database (135) of transcription 
factor binding sites detected by ChIP, the JASPAR and TRANSFAC position weight 
matrices, as well as various protein-protein interaction and kinase-substrate databases to 
connect kinase signaling events to gene expression patterns. The top 20 transcription factors 
linked to signaling and cluster #9 transcripts in a 2011 analysis were used as the X2K 
predictions.
 Quantitative RT-PCR
RNA from cultured cells was isolated with the RNeasy Plus Mini Kit (Qiagen) according to 
the manufacturer’s protocol. First-strand complementary DNA synthesis and qRT-PCR were 
performed as described (63). Parental HT-29 samples were normalized to the geometric 
mean of GAPDH, HINT1, PPIA, and PRDX6. GATA6L addback samples were normalized 
to the geometric mean of GAPDH, HINT1, PPIA, PRDX6, B2M, and GUSB. Primer 
sequences are available in table S2.
 Mass spectrometry
HT-29 cells stably expressing doxycycline-inducible 3×FLAG-GATA6L were induced with 1 
doxycycline (1 μg/ml) for 24 hours and lysed in NP-40 lysis buffer plus protease and 
phosphatase inhibitors (51). Protein extract (60 mg) in 6-ml volume was first cleared with 50 
μl of mouse IgG–agarose beads (Sigma) for 1 hour at 4°C on a nutator. The cleared lysates 
were subjected to immunopurification using 80 μl of anti-FLAG M2 affinity gel (Sigma) for 
3 to 4 hours followed by two washes with NP-40 lysis buffer, one wash with 500 mM NaCl, 
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and one wash with tris-buffered saline. Immunoprecipitates were eluted with 3×FLAG 
peptide (500 ng/ml; Sigma) in 100 μl for 30 min at 4°C on a nutator. The eluate was 
concentrated using an Amicon ultra centrifugal filter (Millipore), and samples were prepared 
in dithiothreitol-containing Laemmli sample buffer and separated by SDS polyacrylamide 
gel electrophoresis on an 8% polyacrylamide gel followed by Coomassie brilliant blue 
staining. The stained bands were cut and subsequently reduced, alkylated, and digested with 
trypsin, chymotrypsin, or pepsin. Peptides from each enzymatic digestion were acrylamide-
extracted and subjected to liquid chromatography–mass spectrometry on a Thermo Electron 
Orbitrap Velos ETD mass spectrometer system. The data were analyzed using the Sequest 
search algorithm against the International Protein Index human proteome database and the 
predicted GATA6 protein sequence. Full mass spectrometry details are available in texts S1 
and S2.
 Immunoblotting
Quantitative immunoblotting was performed as described previously in detail (51) with 
primary antibodies recognizing the following proteins or epitopes: phospho-GATA6L (Ser37, 
Covance, 1:1000 for crude antiserum and 1:500 after affinity purification), non–phospho-
GATA6L (Ser37, Covance, 1:500), GATA6 (D61E4, Cell Signaling Technology #5851, 
1:2000), GATA6 (H-92, Santa Cruz Biotechnology #9055, 1:600), phospho-GS (Ser641, Cell 
Signaling Technology #3891, 1:1000), GS (Cell Signaling Technology #3893, 1:1000), 
GSK3α (Cell Signaling Technology #9338, 1:1000), phospho-GSK3α (Ser21, Cell Signaling 
Technology #9316, 1:1000), phospho-Akt (Ser473, Cell Signaling Technology #4060, 
1:1000), Akt (Cell Signaling Technology #9272, 1:1000), phospho-S6 (Ser240/244, Cell 
Signaling Technology #5364, 1:1000), S6 (54D2, Cell Signaling Technology #2317, 
1:1000), FLAG (M2, Sigma #F1804, 1:10,000), β-actin (Ambion #4302, 1:5000), vinculin 
(Millipore #05-386, 1:10,000), GAPDH (Ambion #4300, 1:20,000), tubulin (Abcam 
#89984, 1:20,000), and p38 (C-20, Santa Cruz Biotechnology #535, 1:5000). Membrane 
blocking, antibody probing, and near-infrared fluorescence detection were performed as 
described (51), except for phospho-GATA6 (Ser37) immunoblotting, where blocking with 
5% nonfat skim milk and use of tris-buffered saline buffers were required.
Phos-tag immunoblotting was performed on a 6% polyacrylamide gel containing 10 μM 
Phos-tag acrylamide AAL-107 (Wako Chemicals) and 0.1 μM MnCl2. Gels were run with 
WIDE-VIEW prestained protein markers under constant current (40 mA) for 170 min. 
Before electrophoretic transfer, gels were incubated with 1 mM EDTA in modified Towbin’s 
transfer buffer (51) for 15 min. Membrane blocking, antibody probing, and near-infrared 
fluorescence detection were then performed as described (51).
For Gaussian mixture modeling of GATA6L forms, raw 16-bit pixel intensities were 
integrated horizontally across each lane and then plotted along the vertical dimension. Using 
the fit function in MATLAB, the vertical trace was fit by nonlinear least-squares to the 
following function:
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where f(x) is height of the vertical trace as a function of the vertical position x, b is a fixed 
background, w1 and w2 are the relative weights of the two bands, μ1 and μ2 are the mean 
vertical positions of the two bands, and σ2 is a shared variance for the two bands. 
Normalized versions of w1 and w2 were taken as the relative band densities for the two 
forms.
 Phospho-GATA6L (Ser37) immunoprecipitation
HT-29 cells were plated at 75,000 cells/cm2, pretreated with human IFNγ for 24 hours 
(Roche), and then treated with TNF (100 ng/ml; PeproTech), insulin (500 ng/ml; Sigma), or 
both for 1 hour. Cells were lysed in NP-40 lysis buffer (51) supplemented with 10 mM 
sodium pyrophosphate and 30 mM sodium fluoride, and ~4 mg of cellular extract (adjusted 
according to total GATA6L abundance based on immunoblotting) was incubated with 10 μl 
of phospho-GATA6L (Ser37) antiserum overnight on a nutator at 4°C. The following day, 30 
μl of Protein A/G Plus UltraLink resin (Thermo) was added to the immune complexes for 1 
hour on a nutator at 4°C. Beads were washed twice with ice-cold supplemented NP-40 lysis 
buffer and twice with ice-cold phosphate-buffered saline (PBS) before elution in Laemmli 
sample buffer (136). Samples were electrophoresed on a 10% polyacrylamide gel for 3 to 5 
hours (until the 50-kD marker reached the bottom of the gel) before proceeding with 
quantitative immunoblotting as described (51). Densitometry was performed by integrating 
the pixel intensity (without lane-specific background subtraction) of the 75-kD band and, for 
the 60-kD form, the intensity between the 75-kD band and the upper shoulder of the 
immunoprecipitating antibody heavy chain (file S5).
 Chromatin immunoprecipitation
Five million wild-type and S37A GATA6L-addback HT-29 cells were seeded in 10-cm 
culture plates for 24 hours before inducing knockdown-addback with doxycycline (1 μg/ml) 
for 48 hours. Cells were fixed for 7 to 10 min by adding a 37% formaldehyde stock to the 
culture medium to a final concentration of 1%. Fixation was quenched with 1/20 volume of 
2.5 M glycine for 7 to 10 min at room temperature. Cells were washed twice with cold PBS, 
scraped into 1 ml of PBS, and centrifuged at 400 relative centrifugal force (rcf) for 3 min. 
The cell pellets from four 10-cm plates were combined and lysed in ChIP lysis buffer (96) to 
a final volume of 1.5 ml. Lysates were incubated on ice for 10 min and then sonicated using 
a Branson digital sonifier for 5 min at 40% amplitude with 0.7 s “on” and 1.3 s “off” pulse 
cycles. After centrifugation at 14,000 rcf for 20 min, the supernatant was collected, and 20 
μl of the soluble chromatin was retained as the input fraction. Soluble chromatin was diluted 
10-fold in dilution buffer (96), precleared with 100 μl of mouse IgG–conjugated agarose 
beads (Sigma) for 4 hours at 4°C with constant agitation, and then incubated with 100 μl of 
anti-FLAG M2 affinity gel (Sigma) or mouse IgG–conjugated agarose beads overnight at 
4°C with constant agitation. Agarose beads were collected and washed as previously 
described (96). DNA from the beads and the input fraction was eluted by reversing 
methylene cross-links with 500 μl of elution buffer (96) at 65°C for 5 hours. Samples were 
then treated with ribonuclease (100 μg/ml) for 30 min at 37°C and proteinase K (200 μg/ml) 
for 90 min at 50°C, followed by phenol-chloroform extraction. The aqueous fraction was 
ethanol-precipitated, washed once in 70% ethanol, air-dried, and dissolved in nuclease-free 
water. The samples were diluted 10-fold in nuclease-free water and quantified by PCR with 
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primers designed for proximal promoter regions of selected crosstalk genes (123). Primer 
sequences are available in table S3.
 Statistical analysis
Microarray data were analyzed by four-way ANOVA (factors: TNF, EGF, insulin, and time) 
in MATLAB with the anovan function at a false discovery rate of 5% (file S1). qRT-PCR 
data of cluster #9 genes were analyzed by four-way ANOVA (factors: transcript, TNF, 
insulin, and time) or, for GATA6L addback, by five-way ANOVA (factors: GATA6L 
genotype, transcript, TNF, insulin, and time) in MATLAB with the anovan function after log 
transformation. Half-lives of GATA6L forms were estimated by nonlinear least-squares 
curve fitting to the following function:
where g(t) is the relative band intensity as a function of time t, c is the scaling coefficient, b 
is a fixed background, and τ1/2 is the half-life. Differences in means were assessed by 
Welch’s t test, and differences in geometric means were assessed by Welch’s t test after log 
transformation. One- or two-sidedness was based on previous evidence or expectation for a 
directional change. Tests for enrichment were performed by binomial test. Differences 
between immunoblotting time courses were assessed by two-way ANOVA.
 Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Fig. 1. A compendium of ligand--induced signals and transcriptional responses
(A) Overview of the experimental design. HT-29 cells were pretreated with IFNγ, stimulated 
with various combinations and concentrations of TNF, EGF, and insulin, and profiled for the 
indicated signaling receptors, adaptors, and effectors by kinase assay (KA), immunoblot 
(IB), or antibody array (AA) and for the associated transcriptomic signatures by microarray. 
The goal is to determine whether global ligand-induced mRNA regulatory states (Y) can be 
predicted from the upstream signaling network activation (X). (B) Hierarchical clustering of 
the signaling compendium for saturating (High) and subsaturating (Low) concentrations of 
TNF, EGF, and insulin (42, 43). Data are means of n = 3 to 6 independent biological 
replicates. (C) Hierarchical clustering of the dynamic transcriptomic responses resulting 
from the ligand combinations in (B). Data are means of n = 2 independent biological 
replicates.
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Fig. 2. Structuring and modeling biological data sets as tensors
(A) Structured data sets are conventionally unfolded with time to create a concatenated data 
matrix of ns signals and nt time points. Using the unfolded matrix, data-driven modeling 
approaches (20) treat each time point of each signal as a separate predictor variable, yielding 
ns × nt regression (regr) coefficients that must be inferred. (B) Recasting stimulus-signal-
time data sets as a third-order tensor. The tensor structure (X) considers each time point as a 
predictor variable for all signals and each signal as a predictor variable for all time points, 
resulting in ns + nt regression coefficients and thus a more parsimonious model. (C) A 
dependent third-order transcriptomic tensor (Y) structured by stimulus, nc gene clusters, and 
nt2 time points. (D) Decomposing third-order data tensors as sums of latent variables 
composed of triple products. The decomposed tensor for each latent variable is reconstructed 
as the triple product (purple) of a scores vector (t or u) and two weight vectors (wj and wk or 
ql and qm). Latent variables are iteratively calculated to capture the maximum covariance 
between X and Y that remains from the preceding latent variable. X and Y are connected by 
a linear inner relationship between t and u with slope = b. (E) Prediction with tensor models 
involves projecting a new stimulus onto the latent variables of X, predicting the dependent 
scores vector u from the linear inner relationship (u = bt), and then backprojecting onto the 
latent variables of Y.
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Fig. 3. A tensor PLSR model linking ligand-induced signaling and changes in transcript 
abundance
(A) Time-unfolded measurements of transcriptional clusters (blue) compared to cross-
validated predictions of the tensor PLSR model (brown). Standardized z scores of measured 
transcriptional clusters are means ± SD of n = 897 (#1), 841 (#2), 119 (#3), 106 (#4), 66 
(#5), 49 (#6), 42 (#7), 33 (#8), and 26 (#9) probe sets (file S2). High (H) indicates saturating 
concentration of ligand, 0 indicates absence of ligand, and low (L) indicates subsaturating 
concentration of ligand. (B) Latent variable time weights for the signaling and 
transcriptomic tensors. LV#4 has a negative inner relationship (orange), indicating that LV#4 
signaling is anticorrelated with LV#4 transcription. (C to E) Projections of the indicated 
stimulus conditions (C), signals (D), and transcriptional clusters (E) onto LV#3 and LV#4. 
For (D) and (E), the null projections of reshuffled data tensors are means (solid gray) ± SD 
(dashed gray) of n = 500 randomizations (79). In (D), the type of assay used to measure the 
signaling protein is indicated in parentheses (see Fig. 1A for details). ClvC8, cleaved 
caspase 8; ProC3, procaspase 3; ProC8, procaspase 8; lowercase p prefix represents 
phosphorylated protein; lowercase t prefix represents total protein; lowercase pt prefix 
represents XXX.
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Fig. 4. Multipronged bioinformatics of TNF-insulin crosstalk suggests posttranslational 
regulation from GSK3 to GATA6
(A to D) qRT-PCR validation of selected cluster #9 transcripts upon pretreatment of HT-29 
cells with IFNγ and stimulation with TNF with or without insulin for 2 hours (A and B) or 6 
hours (C and D)). Data are geometric means ± log-transformed SEM of n = 4 or 16 
biological replicates. Full cluster #9 data are shown in fig. S5. (E) Promoter bioinformatics 
(86, 92, 93) suggest GATA and TCF4 as candidate regulators of TNF-insulin crosstalk. (F) 
Relative copy number estimates (96, 97) for the six GATA isoforms in HT-29 cells. Data are 
medians ± range of n = 3 biological replicates. n.d., not detected. (G to I) Transcriptional 
dynamics of GATA isoforms in response to TNF and insulin. Data are geometric means ± 
log-transformed SEM of n = 4 or 8 biological replicates. (J) Scansite (98) identification of 
candidate GSK3 phosphorylation sites (red). Each site’s percentile rank is averaged across 
the indicated sequences. (K) Phospho-mass spectrometry identifies 11 phosphorylation sites 
on GATA6L. Previously unreported sites (New) are shown below the primary sequence, 
those consistent with reports in the literature (104) (Reported) are shown above, and 
reported sites not detected in this study are gray. Start methionines (arrows) for the long and 
short forms are indicated along with the conserved GATA core and zinc finger (ZnF) 
domains.
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Fig. 5. GATA6L abundance is not altered by prolonged rapamycin treatment or feedback 
phosphorylation of Akt
(A) HT-29 cells exhibit rapamycin-induced feedback phosphorylation of Akt, but do not 
stabilize GATA6. a.u., arbitrary units. (B) AC16 cells exhibit stabilization of GATA6S, but 
not GATA6L, without rapamycin-induced feedback phosphorylation of Akt. Vinculin,, 
tubulin, and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) used as loading controls 
(51). Quantitative immunoblot data are means ± SEM of n = 4 biological replicates across 
two separate experiments.
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Fig. 6. Extensive phosphorylation of GATA6L is blocked by S37A mutation, reversed by TNF 
stimulation, and stabilized in HT-29 cells
(A) Electrophoretic mobility of FLAG-tagged GATA6L is downshifted upon S37A mutation 
in lipofected 293T cells. (B) Phos-tag electrophoresis (112) reveals that TNF stimulation for 
1 hour causes the dephosphorylation of GATA6L. (C and D) Phos-tag electrophoresis (C) 
and quantification (D) of the upper and lower forms of GATA6L in response to IFNγ 
sensitization for 24 hours, pretreatment with 1 μM CT99021 for 1 hour, and stimulation with 
TNF or insulin for one1 hour. Data are median proportion ± range of n = 3 biological 
replicates. (E and F) Doxycycline (DOX)–inducible addback in HT-29 cells replaces 
endogenous GATA6S with epitope-tagged GATA6L. Cells were treated with doxycycline (1 
μg/ml) for 48 hours. (G and H) The less phosphorylated form of wild-type (WT) GATA6L is 
unstable. Cells were treated with TNF (100 ng/ml) + 50 μM cycloheximide for the indicated 
times, and half-lives were estimated by nonlinear least-squares curve fitting. Quantitative 
immunoblot data are means ± SEM of n = 3 (F and H) or 5 to 6 (B) biological replicates.
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Fig. 7. Phosphorylation and destabilization of endogenous GATA6L at 60 kD
(A) Knockdown (shGATA6) and FLAG-tagged addback of GATA6L at ~60 kD (red). 
Samples were immunoblotted for total (modified and unmodified) GATA6 (upper), FLAG 
(lower), and the indicated loading controls. (B) Destabilization of the 60-kD form of WT 
GATA6L compared to the S37A-mutant addback cells. (C and D) Endogenous phospho-
GATA6L (Ser37) immunoreactivity is not detectably affected by stimulation with TNF for 1 
hour, inhibition with 20 μM CT99021 for 6 hours, or both. (E and F) Phosphorylation and 
destabilization of the 60-kD form of GATA6L upon serum starvation. Specificity was 
confirmed by preincubation of cells with 20 μM CT99021 for 1 hour before serum 
starvation. (G and H) Phospho-GATA6L (Ser37) immunoprecipitation and total GATA6 
immunoblot of HT-29 cells pretreated with IFNγ and stimulated with TNF ± insulin for 1 
hour. The gamma of the immunoprecipitation image is set to 1.5 to minimize background 
from the immunoprecipitating antibody heavy chain. Input (0.5% input%) of each 
immunoprecipitate was immunoblotted for total GATA6 and the indicated loading controls. 
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See file S5 for details. Data are means ± SEM of n = 3 (B, E, F, and H) or 6 (C and D) 
biological replicates.
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Fig. 8. S37A mutation of GATA6L mimics and competes with the repression of transcript 
abundance in the TNF-insulin crosstalk cluster
(A) Doxycycline-inducible overexpression of WT GATA6L in HT-29 cells. Cells were 
treated with doxycycline (1 μg/ml) for 24 hours. (B) Ratio of TNF-induced transcript 
abundance for crosstalk cluster genes in the presence or absence of GATA6L overexpression. 
Data are mean ratios of n = 3 independent biological samples assessed by microarray 
profiling, with bias in the ratio assessed by two-sided binomial test. (C) S37A mutation of 
GATA6L mimics insulin stimulation (green) and antagonizes TNF-insulin crosstalk (purple). 
qRT-PCR data for cluster #9 genes in WT and S37A mutant (S37A) GATA6L addback cells 
pretreated with IFNγ and stimulated with TNF, insulin, or both for 2 or 4 hours. Data are 
row-standardized geometric means of n = 6 biological replicates across two separate 
experiments, with interactions between GATA6 status and TNF or insulin assessed by log-
transformed five-way ANOVA with the following factors: GATA6, transcript, TNF, insulin, 
and time. (D) Three-state conceptual model for GATA6L regulation by TNF and insulin and 
its relation to the crosstalk cluster of transcripts. Ovals annotate the figure subpanels 
supporting the links depicted.
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Fig. 9. Diversity of GATA6L forms across different cell lineages
(A to D) Arrows indicate the GATA6 forms confirmed earlier by knockdown or observed 
with multiple antibodies. Red asterisks indicate nonspecific bands. The MCF10A-5E and 
AC16 samples are on an immunoblot; HT-29, HCT-8, and DLD-1 are on another blot. The 
blots have been scaled to match. Data are representative of n ≥ 3 independent experiments.
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